FDA Inspection 1301794 — American Red Cross Blood Services
The FDA completed an inspection of American Red Cross Blood Services on Jan 22, 2026 in Lenexa, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 22, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lenexa, KS (United States)